Atlas Trials

Safety, Tolerability and Pharmacokinetics of Escalating Single Doses of ENV8058 (TAK-058) in Healthy Participants

Clinical trial NCT02153099 · COMPLETED

Trial details

NCT number
NCT02153099
Sponsor
Takeda
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Dose Finding Study
Start date
2014-06-01
Primary completion
2014-11-01
Enrollment
48

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.